Avanir Announces New Data on its Imitrex-based Drug

Monday, October 7th, 2013

Avanir Pharmaceuticals recently announced that the results of the study on its new drug, AVP-825, will be published in the journal ‘Headache’. AVP-825 is a Breath Powered device based on sumatriptan (Imitrex). It delivers the medication in power form intra-nasally for treating acute migraines. The results to be published will be on a randomized study […]